Larson Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Buy
4,429
+1,235
+39% +$103K 0.01% 619
2026
Q1
$256K Buy
3,194
+697
+28% +$57.5K 0.01% 648
2025
Q4
$213K Sell
2,497
-451
-15% -$37K 0.01% 684
2025
Q3
$229K Buy
2,948
+227
+8% +$17.7K 0.01% 653
2025
Q2
$213K Sell
2,721
-2,312
-46% -$172K 0.01% 646
2025
Q1
$365K Buy
5,033
+1,618
+47% +$116K 0.02% 475
2024
Q4
$253K Sell
3,415
-976
-22% -$68.3K 0.01% 512
2024
Q3
$290K Buy
4,391
+2,923
+199% +$212K 0.02% 481
2024
Q2
$136K Buy
1,468
+1,444
+6,017% +$128K 0.01% 570
2024
Q1
$2.29K Hold
24
﹤0.01% 1343
2023
Q4
$1.83K Sell
24
-62
-72% -$4.31K ﹤0.01% 1382
2023
Q3
$5.96K Buy
86
+70
+438% +$5.63K ﹤0.01% 1127
2023
Q2
$1.51K Sell
16
-75
-82% -$6.52K ﹤0.01% 1318
2023
Q1
$7.53K Buy
91
+45
+98% +$3.54K ﹤0.01% 997
2022
Q4
$3.43K Buy
+46
New +$3.54K ﹤0.01% 1104
2022
Q2
Sell
-30
Closed -$4K 1217
2022
Q1
$4K Hold
30
﹤0.01% 817
2021
Q4
$4K Buy
+30
New +$3.5K ﹤0.01% 851
2020
Q1
Sell
-30
Closed -$2K 569
2019
Q4
$2K Buy
+30
New +$2.34K ﹤0.01% 444

Other funds holding EW

Larson Financial Group's EW Position: Q2 2026 in Review

Larson Financial Group increased its Edwards Lifesciences (EW) stake by 39% in Q2 2026, buying an estimated $103K and bringing the position to 4,429 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #619.

Larson Financial Group first reported a position in EW in Q4 2019 and has held it in 18 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Larson Financial Group held 4,429 shares of Edwards Lifesciences worth $401K as of Q2 2026.
  • Larson Financial Group bought 1,235 Edwards Lifesciences shares in Q2 2026, an estimated $103K.
  • Edwards Lifesciences made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #619 holding.
  • Larson Financial Group first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 18 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.